Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY Fleischer, D. M., Shreffler, W. G., Campbell, D. E., Green, T. D., Anvari, S., Assa'ad, A., Begin, P., Beyer, K., Bird, J., Brown-Whitehorn, T., Byrne, A., Chan, E. S., Cheema, A., Chinthrajah, S., Chong, H., Davis, C. M., Ford, L. S., Gagnon, R., Greenhawt, M., Hourihane, J., Jones, S. M., Kim, E. H., Lange, L., Lanser, B. J., Leonard, S., Mahler, V., Maronna, A., Nowak-Wegrzyn, A., Oriel, R. C., O'Sullivan, M., Petroni, D., Pongracic, J. A., Prescott, S. L., Schneider, L. C., Smith, P., Staab, D., Sussman, G., Wood, R., Yang, W. H., Lambert, R., Peillon, A., Bois, T., Sampson, H. A. 2020; 146 (4): 863–74

View details for Web of Science ID 000582395800017